Liver transplantation for small hepatocellular carcinoma: The tumor- node-metastasis classification does not have prognostic power

Hepatology

Volumn 27, Issue 6, 1998, Pages 1572-1577

  Llovet, Josep M ^a   Bruix, Jordi ^a,b   Fuster, Josep ^a   Castells, Antoni ^a   Garcia Valdecasas, Juan Carlos ^a   Grande, Lluís ^a   França, Alex ^a   Brú, Concepció ^a   Navasa, Miquel ^a   Del Carmen Ayuso, Maria ^a   Solé, Manel ^a   Real, Maria Isabel ^a   Vilana, Ramon ^a   Rimola, Antoni ^a   Visa, Josep ^a   Rodés, Joan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; RECURRENCE; SURVIVAL ANALYSIS;

EID: 17344364935     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270616     Document Type: Article

References (27)

1. Johnson PJ, Williams R. Cirrhosis and the etiology of hepatocellular carcinoma. J Hepatol 1987;4:140-147.
2. Okuda K. Hepatocellular carcinoma: recent progress. HEPATOLOGY 1992; 15:948-963.
3. Iwatsuki S, Gordon RD, Shaw BW, Starzl TE. Role of liver transplantation in cancer therapy. Ann Surg 1985;202:401-407.
4. O'Grady JG, Polson RJ, Rolles K, Calne RY, Williams R. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg 1988;207:373-379.
5. Ringe B, Wittekind C, Bechstein WO, Bunzendahl H, Pichlmayr R. The role of liver transplantation in hepatobiliary malignancy. Ann Surg 1989;209:88-98.
6. Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 1991;110:726-773.
7. Yokoyama I, Todo S, Iwatsuki S, Starzl TE. Liver transplantation in the treatment of primary liver cancer. Hepato-gastroenterol 1990;37:188-193.
8. Yokoyama I, Sheahan DG, Carr B, Kakizoe S, Selby R, Tzakis AG, Todo S, et al. Clinicopathologic factors affecting patient survival and tumor recurrence after orthotopic liver transplantation for hepatocellular carcinoma. Transplant Proc 1991;23:2194-2196.
9. McPeake JR, O'Grady JG, Zaman S, Portmann B, Wight DG, Tan KC, Calme RY, et al. Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome. J Hepatol 1993;18:226-234.
10. Pichlmayr R, Weimann A, Oldhafer KJ, Schlitt HY, Klempnauer J, Bornscheuer A, Chavan A, et al. Role of liver transplantation in the treatment of unresectable liver cancer. World J Surg 1995;19:807-813.
11. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A. Liver transplantation for treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
12. Figueras J, Jaurrieta E, Valls C, Benasco C, Rafecas A, Xiol X, Fabregat J, et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. HEPATOLOGY 1997;25:1485-1489.
13. Schwartz ME. Liver transplantation for hepatocellular carcinoma: The best treatment, but for which patient? HEPATOLOGY 1996;24:1539-1541.
14. Fuster J, Garcia-Valdecasas JC, Grande L, Tabet J, Bruix J, Anglada T, Taura P, et al. Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. Ann Surg 1996;223:297-302.
15. Makuuchi M. Surgical treatment for hepatocellular carcinoma. In: Arroyo V, Bosch J, Rodés J, eds. Treatments in Hepatology. Barcelona: Masson, 1995;341-352.
16. Okada S, Shimada K, Yamamoto J, Takayama T, Kosuge T, Yamasaki S, Sakamoto M, et al. Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 1994;106:1618-1624.
17. Izumi R, Shimizu K, Ii T, Yagi M, Matsui O, Nonomura A, Miyazaki I. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 1994;106:720-727.
18. Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sánchez-Tapias JM, Ventura M, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989;2:1004-1006.
19. Gane E, Naoumov N, Qian K, Mondelli M, Maertens G, Portmann B, Lau J, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996;110:167-177.
20. Araya V, Rakela J, Wright T. Hepatitis C after orthotopic liver transplantation. Gastroenterology 1997;112:575-582.
21. Feray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, Urdea M, et al. The course of hepatitis C infection after liver transplantation. HEPATOLOGY 1994;20:1137-1143.
22. Castells A, Bruix J, Brú C, Fuster J, Vilana R, Navasa M, Ayuso C, et al. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. HEPATOLOGY 1993;18:1121-1126.
23. Bruix J, Castells A, Montanyà X, Calvet X, Brú C, Ayuso C, Jover LI, et al. Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: need for controlled trials. HEPATOLOGY 1994; 20:643-650.
24. Castells A, Bruix J, Brú C, Ayuso C, Roca M, Boix L, Vilana R, et al. Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients. Gastroenterology 1995;109:917-922.
25. Bruix J, Llovet JM, Castells A, Brú C, Montana X, Vilana R, Ayuso C, et al. Treatment of hepatocellular carcinoma by transarterial embolization: a prospective placebo controlled trial [Abstract]. HEPATOLOGY 1997;26: 249A.
26. Sorensen JB, Klee M, Palshof T, Hansen HH. Performance status assessment in cancer patients. An inter-observer variability study. Br J Cancer 1993;67:773-775.
27. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Haregawwa H, Nakajima Y, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 1985;56:918-928.